Investor mix
14 investors on record; lead investors include Kleiner Perkins, WI Harper Group, Element Capital, Panacea Venture.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 57% |
| Private equity | 1 | 7% |
| Other / undisclosed | 5 | 36% |
Developer of drugs for treating neurological disorders like epilepsy, Parkinson's & others
14 investors on record; lead investors include Kleiner Perkins, WI Harper Group, Element Capital, Panacea Venture.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 57% |
| Private equity | 1 | 7% |
| Other / undisclosed | 5 | 36% |